Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA: a phase 3, double-blind, randomised, placebo-controlled multicentre trial

Authors: Lipton et al.

Lancet Neurol. 2023 Mar;22(3):209-217.

PMID: 36804093 | DOI: 10.1016/S1474-4422(22)00517-8

See related Comment.

Sign Up For An MSC Newsletter

Apply for an AMD/MSC Travel Grant!

The Association of Migraine Disorders and Migraine Science Collaborative are now accepting applications for travel grants! These grants will support travel to the American Headache Society's upcoming 65th Annual Scientific Meeting. Learn more and apply now!

Discussion

Search

  • Content Types

  • Paper Categories

  • Paper Dates

Paper Categories

By Date